Rice William G. 4
4 · Aptose Biosciences Inc. · Filed Nov 26, 2024
Insider Transaction Report
Form 4
Rice William G.
DirectorChair, President & CEO
Transactions
- Purchase
Common Shares
2024-11-25$0.20/sh+100,000$20,000→ 613,252 total - Purchase
Warrants
2024-11-25+50,000→ 50,000 totalExercise: $0.25From: 2024-11-25Exp: 2029-11-25→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Shares and warrants were acquired as part of an Issuer unit offering, each unit priced at $0.20 consisting of one common share and one-half of one common share purchase warrant.